Unicycive Therapeutics (UNCY) Payables (2020 - 2026)
Unicycive Therapeutics (UNCY) recorded Payables of $2.23 million in Q2 2026, up 188.3% from $775,000 a year earlier and up 96.0% from the prior quarter.
Powered by 
Analysis
Unicycive Therapeutics (UNCY) Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, Unicycive Therapeutics reported Payables of $383,000, down 63.8% from FY2024.
- Annual Payables has a five-year compound annual growth rate of -25.9% (FY2020 to FY2025).
- Across earlier years, Payables came in at $1.06 million in FY2024 (-47.1%), $2 million in FY2023 (+124.2%), $892,000 in FY2022 (+20.2%) and $742,000 in FY2021 (-56.7%).
- The Q2 2026 figure is the highest quarterly Payables since Q3 2022.
- On a year-over-year basis, Payables rose in three of the last eight quarters, with growth averaging 6.2%.
- Peak year-over-year performance for Payables in the last five years was growth of 192.8% in Q2 2024, against a decline of 79.0% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.14 million (Q1 2026), $383,000 (Q4 2025) and $957,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,155.80 Bn | 1,124.39 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 630.65 Bn | 549.18 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 502.74 Bn | 475.85 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 375.34 Bn | 329.72 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 301.36 Bn | 265.35 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 265.02 Bn | 238.70 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 239.16 Bn | 194.55 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 192.63 Bn | 166.82 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 171.82 Bn | 118.47 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Unicycive Therapeutics | 105.78 Mn | -94.19 Mn | - | 2.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.23 Mn |
| Mar 31, 2026 | 1.14 Mn |
| Dec 31, 2025 | 383,000.00 |
| Sep 30, 2025 | 957,000.00 |
| Jun 30, 2025 | 775,000.00 |
| Mar 31, 2025 | 1.40 Mn |
| Dec 31, 2024 | 1.06 Mn |
| Sep 30, 2024 | 548,000.00 |
| Jun 30, 2024 | 1.47 Mn |
| Mar 31, 2024 | 1.24 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Sep 30, 2023 | 1.08 Mn |
| Jun 30, 2023 | 503,000.00 |
| Mar 31, 2023 | 790,000.00 |
| Dec 31, 2022 | 892,000.00 |
| Sep 30, 2022 | 2.29 Mn |
| Jun 30, 2022 | 747,000.00 |
| Mar 31, 2022 | 589,000.00 |
| Dec 31, 2021 | 742,000.00 |
| Sep 30, 2021 | 49,000.00 |
API Access
Unicycive Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=UNCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "UNCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=UNCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();